Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/26 16:45 | 3/10/26 | GILD | Health | BioPrd | Biological Products, (No Diag | Dickinson Andrew D | CA | O | CFO | 4 | M.d | 1,202 | 77.72 | 0 | 15 | 9 | 182 | D | ||||||||||||||
3/12/26 16:42 | 3/10/26 | GILD | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | 5 | M.d | 6,729 | 102.55 | 0 | 66 | 95 | 135 | D | ||||||||||||||
3/12/26 16:39 | 3/10/26 | GILD | Health | BioPrd | Biological Products, (No Diag | Cain Wettan Keeley M | CA | O | EVP GC, | 1 | M.d | 0 | 0.00 | 0 | 1 | 33 | 5 | D | ||||||||||||||
3/12/26 16:24 | 3/10/26 | GILD | Health | BioPrd | Biological Products, (No Diag | O'Day Daniel Patrick | CA | DO | CB,CEO | 8 | M.d | 52,319 | 102.07 | 0 | 513 | 366 | 653 | D | ||||||||||||||
3/12/26 16:22 | 3/10/26 | GILD | Health | BioPrd | Biological Products, (No Diag | Berger Dietmar | CA | O | Chief Me | 2 | M.d | 0 | 0.00 | 0 | 18 | 999% | 19 | D | ||||||||||||||
1/21/26 16:26 | 1/20/26 | GILD | Health | BioPrd | Biological Products, (No Diag | Bluestone Jeffrey | CA | D | 2 | M.d | 955 | 95.48 | 0 | 10 | 9 | D | ||||||||||||||||
1/21/26 16:26 | 1/20/26 | GILD | Health | BioPrd | Biological Products, (No Diag | Bluestone Jeffrey | CA | D | 2 | S.d | -955 | 95.48 | 0 | -10 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |